CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
REVENUES:
Product revenue	$ 4,620,841	$ 3,363,692	$ 8,627,139	$ 5,956,855
License and other revenue	35,709	35,709	71,417	71,417
Total Revenues	4,656,550	3,399,401	8,698,556	6,028,272
OPERATING EXPENSES
Cost of product revenue (exclusive of amortization expense shown below)	9,645,662	4,334,019	21,888,410	5,950,306
Research and development	1,472,100	1,358,409	2,753,806	2,551,136
Plasma centers	1,738,128	1,600,170	3,571,902	3,079,646
Amortization of intangibles	211,234	73,021	422,469	73,021
Selling, general and administrative	5,006,807	4,435,650	10,011,853	8,713,034
TOTAL OPERATING EXPENSES	18,073,931	11,801,269	38,648,440	20,367,143
LOSS FROM OPERATIONS	(13,417,381)	(8,401,868)	(29,949,884)	(14,338,871)
OTHER INCOME (EXPENSE):
Interest income	33,070	7,858	59,616	26,426
Interest expense	1,359,188	642,485	2,682,340	1,261,013
Other (expense) income	(4,332)	0	2,635	0
OTHER EXPENSE, NET	(1,330,450)	(634,627)	(2,620,089)	(1,234,587)
NET LOSS	$ (14,747,831)	$ (9,036,495)	$ (32,569,973)	$ (15,573,458)
BASIC AND DILUTED LOSS PER COMMON SHARE	$ (0.35)	$ (0.55)	$ (0.74)	$ (1.06)
WEIGHTED AVERAGE SHARES OUTSTANDING, Basic and Diluted	42,712,168	16,427,054	44,007,409	14,666,677